Feasibility and Impact of a Prehabilitation and Rehabilitation Program for the Continuity of Care in Severe Low Anterior Resection Syndrome.
Launched by HOSPITAL DONOSTIA · Oct 27, 2020
Trial Information
Current as of July 23, 2025
Unknown status
Keywords
ClinConnect Summary
-Study design: A single-arm, non-randomized prospective study that will initially evaluate the compliance and feasibility of a prehabilitation and / or functional rehabilitation program in patients with anterior rectal resection with mesorectal excision for rectal cancer. In addition, clinical outcome variables will be obtained to evaluate the possibility of a subsequent efficacy study.
-Patient selection: Participation in this study will be proposed to all consecutive patients with rectal cancer who are expected to perform a low anterior resection of the rectum with mesorectal excision an...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Low anterior resection of the rectum with mesorectal excision and colorectal anastomosis with or without protective ileostomy
- • POLARS score \>20
- • over 18 years of age
- • give their informed consent
- • Patients who can perform a pelvic floor physiotherapy program and to tibial nerve stimulation.
- Exclusion Criteria:
- • POLARS score less than 20
- • LARS-minor or non-LARS
- • The existence of residual or distant locoregional disease
- • Inflammatory bowel disease (IBD)
- • A previous known diagnosis of irritable bowel syndrome (IBS)
- • Intestinal resections other than the rectum
- • Existence of anastomotic complications
- • Inability to perform pelvic muscle physiotherapy, presence of trophic disorders in the ankles (post-febile syndrome)
- • Known diabetic neuropathy
- • Carriers of pacemakers or implantable defibrillators, and patients who are have previously performed SNS or PTNS.
About Hospital Donostia
Hospital Donostia is a leading healthcare institution located in San Sebastián, Spain, renowned for its commitment to advancing medical research and patient care. As a prominent clinical trial sponsor, the hospital plays a pivotal role in the development of innovative therapies and treatment modalities across various medical fields. With a multidisciplinary team of experienced healthcare professionals and researchers, Hospital Donostia fosters a collaborative environment that prioritizes ethical standards and patient safety. The institution is dedicated to contributing to the scientific community through rigorous clinical trials that aim to improve health outcomes and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Sebastián, Guipuzcoa, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials